Table 1.
Characteristic | Mean (SD) Or n |
Range | |||
---|---|---|---|---|---|
Number of subjects | |||||
Pregnant | 40 | ||||
Nonpregnant | 20 | ||||
Total | 60 | ||||
Number of subjects on 4 mg or 8 mg dose | |||||
Pregnant | 10/30 | ||||
Nonpregnant | 10/10 | ||||
Total | 20/40 | ||||
Age (years) | |||||
Pregnant | 33.0 (5.2) | 23–43 | |||
Nonpregnant | 37.7 (5.7) | 26–45 | |||
Total | 34.6 (5.8) | 23–45 | |||
Weight (kg) | |||||
Pregnant | 80.7 (12.0) | 60–115 | |||
Nonpregnant | 71.1 (20.5) | 51–126 | |||
Total | 77.5 (15.8) | 51–126 | |||
Height (m) | |||||
Pregnant | 1.64 (0.06) | 1.5–1.75 | |||
Nonpregnant | 1.63 (0.06) | 1.4–1.73 | |||
Total | 1.64 (0.06) | 1.44–1.75 | |||
Gestation period (weeks) | 39.1 (0.746) | 36.4– 40.4 | |||
Delay until delivery after dose (min) | 80.8 (55.5) | 8.0–333 | |||
Number of neonates | 38 | ||||
Weight of neonate at birth(kg) | 3.49 (0.49) | 2.47–4.58 | |||
Height of neonate at birth (cm) | 50.5 (2.12) | 46–55 | |||
Neonatal Gender (n) | |||||
Male | 18 | ||||
Female | 20 |